Gainers
- Windtree Therapeutics (NASDAQ:WINT) shares increased by 56.7% to $1.41 during Thursday's pre-market session. The market value of their outstanding shares is at $8.3 million.
- Sarepta Therapeutics (NASDAQ:SRPT) stock rose 29.81% to $23.86. The market value of their outstanding shares is at $1.8 billion.
- Liminatus Pharma (NASDAQ:LIMN) shares increased by 14.81% to $6.2. The company's market cap stands at $140.4 million.
- Marker Therapeutics (NASDAQ:MRKR) stock increased by 13.12% to $1.81. The company's market cap stands at $17.1 million.
- Rocket Pharmaceuticals (NASDAQ:RCKT) shares increased by 9.79% to $3.14. The market value of their outstanding shares is at $308.1 million.
- Harvard Bioscience (NASDAQ:HBIO) stock rose 8.64% to $0.44. The company's market cap stands at $17.9 million.
Losers
- MEI Pharma (NASDAQ:MEIP) shares decreased by 17.4% to $3.19 during Thursday's pre-market session. The market value of their outstanding shares is at $25.7 million.
- OKYO Pharma (NASDAQ:OKYO) shares decreased by 11.49% to $2.62. The company's market cap stands at $110.7 million.
- Nuwellis (NASDAQ:NUWE) stock declined by 10.98% to $14.2. The company's market cap stands at $69.7 million.
- Aptorum Group (NASDAQ:APM) stock fell 10.83% to $1.73. The market value of their outstanding shares is at $13.8 million.
- Jade Biosciences (NASDAQ:JBIO) shares fell 9.2% to $8.0. The market value of their outstanding shares is at $463.4 million.
- Kairos Pharma (AMEX:KAPA) stock decreased by 8.23% to $1.0. The company's market cap stands at $18.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
HBIOHarvard Bioscience Inc
$0.4420-3.77%
JBIOJade Biosciences Inc
$8.17-1.92%
KAPAKairos Pharma Ltd
Not Available-%
LIMNLiminatus Pharma Inc
$1.73-11.7%
MRKRMarker Therapeutics Inc
$0.95024.42%
NUWENuwellis Inc
$3.464.22%
OKYOOKYO Pharma Ltd
$2.053.54%
RCKTRocket Pharmaceuticals Inc
$3.20-0.32%
SRPTSarepta Therapeutics Inc
$22.701.56%
WINTWindtree Therapeutics Inc
Not Available-%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.